Does Dr. NDUKA AMANKULOR have financial conflicts of interest?

Dr. NDUKA AMANKULOR (MD) has received a total of $33,341 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $33,341 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. NDUKA AMANKULOR?

According to CMS Open Payments data, Dr. NDUKA AMANKULOR received funding from BK MEDICAL HOLDING COMPANY ($28,966), SERVIER PHARMACEUTICALS ($4,038), and NOVOCURE ($170).

Does Dr. NDUKA AMANKULOR receive research grants or speaking fees?

Dr. NDUKA AMANKULOR has received $33,341 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. NDUKA AMANKULOR

MDReal-Time Hydrated

Specialty: Neurological Surgery

Practice Location: PHILADELPHIA, PA 19104

NPI Number: 1033386792

LIFETIME INDUSTRY VALUE

$33,341

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AMANKULOR is a verified Neurological Surgery practitioner based in PHILADELPHIA, PA.

Between 2021 and 2025, Dr. AMANKULOR had an overall industry promotional and research financial footprint of $33,341 as recorded in the federal CMS Open Payments database.

$33,341 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AMANKULOR's primary funding source is BK MEDICAL HOLDING COMPANY, which accounts for $28,966 (representing 86.9% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BK MEDICAL HOLDING COMPANY

Rank 1

$28,966

86.9%

SERVIER PHARMACEUTICALS

Rank 2

$4,038

12.1%

NOVOCURE

Rank 3

$170

0.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.